Cargando…
Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain
BACKGROUND: Updated seroprevalence estimates are important to describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) landscape and to guide public health decisions. The aims are to describe longitudinal changes in seroprevalence in children in a region in Northern Spain and to ana...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514983/ https://www.ncbi.nlm.nih.gov/pubmed/36169886 http://dx.doi.org/10.1007/s12519-022-00617-2 |
_version_ | 1784798391766614016 |
---|---|
author | García-García, Elisa Rodríguez-Pérez, Mercedes Pérez-Solís, David Pérez-Méndez, Carlos Molinos-Norniella, Cristina Cobo-Ruisánchez, Ángeles Fernández Fernández, Eva María González, Noelia García Calle-Miguel, Laura |
author_facet | García-García, Elisa Rodríguez-Pérez, Mercedes Pérez-Solís, David Pérez-Méndez, Carlos Molinos-Norniella, Cristina Cobo-Ruisánchez, Ángeles Fernández Fernández, Eva María González, Noelia García Calle-Miguel, Laura |
author_sort | García-García, Elisa |
collection | PubMed |
description | BACKGROUND: Updated seroprevalence estimates are important to describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) landscape and to guide public health decisions. The aims are to describe longitudinal changes in seroprevalence in children in a region in Northern Spain and to analyze factors associated with SARS-CoV-2 seropositivity. METHODS: Prospective multicenter longitudinal study with subjects recruited from July to September 2020. Children (up to 14 years old) were included and followed up until September 2021. Venous blood samples were collected every six months during three testing rounds and were analyzed for SARS-CoV-2 antibodies. The data regarding epidemiological features, contact tracing, symptoms, and virological tests were collected. The evolution of SARS-CoV-2 seroprevalence during the study and the differences between children with positive and negative SARS-CoV-2 antibody tests were analyzed. RESULTS: Two hundred children were recruited (50.5% girls, median age 9.7 years). The overall seroprevalence increased from round 1 [1.5%, 95% confidence interval (CI) 0.3%–4.3%] to round 2 (9.1%, 95% CI 4.6%–12.7%) and round 3 (16.6%, 95% CI 9.5%–19.6%) (P < 0.001). Main changes occurred in children aged zero to four years (P = 0.001) who lived in urban areas (P < 0.001). None of the children who were previously positive became seronegative. Following multivariable analysis, three variables independently associated with SARS-CoV-2 seropositivity were identified: close contact with coronavirus disease 2019 (COVID-19) confirmed or suspected cases [odds ratio (OR) = 3.9, 95% CI 1.2–12.5], previous positive virological test (OR = 17.1, 95% CI 3.7–78.3) and fatigue (OR = 18.1, 95% CI 1.7–193.4). CONCLUSIONS: SARS-CoV-2 seroprevalence in children has remarkably increased during the time of our study. Fatigue was the only COVID-19-compatible symptom that was more frequent in seropositive than in seronegative children. |
format | Online Article Text |
id | pubmed-9514983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-95149832022-09-28 Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain García-García, Elisa Rodríguez-Pérez, Mercedes Pérez-Solís, David Pérez-Méndez, Carlos Molinos-Norniella, Cristina Cobo-Ruisánchez, Ángeles Fernández Fernández, Eva María González, Noelia García Calle-Miguel, Laura World J Pediatr Original Article BACKGROUND: Updated seroprevalence estimates are important to describe the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) landscape and to guide public health decisions. The aims are to describe longitudinal changes in seroprevalence in children in a region in Northern Spain and to analyze factors associated with SARS-CoV-2 seropositivity. METHODS: Prospective multicenter longitudinal study with subjects recruited from July to September 2020. Children (up to 14 years old) were included and followed up until September 2021. Venous blood samples were collected every six months during three testing rounds and were analyzed for SARS-CoV-2 antibodies. The data regarding epidemiological features, contact tracing, symptoms, and virological tests were collected. The evolution of SARS-CoV-2 seroprevalence during the study and the differences between children with positive and negative SARS-CoV-2 antibody tests were analyzed. RESULTS: Two hundred children were recruited (50.5% girls, median age 9.7 years). The overall seroprevalence increased from round 1 [1.5%, 95% confidence interval (CI) 0.3%–4.3%] to round 2 (9.1%, 95% CI 4.6%–12.7%) and round 3 (16.6%, 95% CI 9.5%–19.6%) (P < 0.001). Main changes occurred in children aged zero to four years (P = 0.001) who lived in urban areas (P < 0.001). None of the children who were previously positive became seronegative. Following multivariable analysis, three variables independently associated with SARS-CoV-2 seropositivity were identified: close contact with coronavirus disease 2019 (COVID-19) confirmed or suspected cases [odds ratio (OR) = 3.9, 95% CI 1.2–12.5], previous positive virological test (OR = 17.1, 95% CI 3.7–78.3) and fatigue (OR = 18.1, 95% CI 1.7–193.4). CONCLUSIONS: SARS-CoV-2 seroprevalence in children has remarkably increased during the time of our study. Fatigue was the only COVID-19-compatible symptom that was more frequent in seropositive than in seronegative children. Springer Nature Singapore 2022-09-28 2022 /pmc/articles/PMC9514983/ /pubmed/36169886 http://dx.doi.org/10.1007/s12519-022-00617-2 Text en © Children's Hospital, Zhejiang University School of Medicine 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article García-García, Elisa Rodríguez-Pérez, Mercedes Pérez-Solís, David Pérez-Méndez, Carlos Molinos-Norniella, Cristina Cobo-Ruisánchez, Ángeles Fernández Fernández, Eva María González, Noelia García Calle-Miguel, Laura Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain |
title | Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain |
title_full | Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain |
title_fullStr | Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain |
title_full_unstemmed | Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain |
title_short | Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain |
title_sort | variation in sars-cov-2 seroprevalence in children in the region of asturias, northern spain |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514983/ https://www.ncbi.nlm.nih.gov/pubmed/36169886 http://dx.doi.org/10.1007/s12519-022-00617-2 |
work_keys_str_mv | AT garciagarciaelisa variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT rodriguezperezmercedes variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT perezsolisdavid variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT perezmendezcarlos variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT molinosnorniellacristina variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT coboruisanchezangeles variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT fernandezfernandezevamaria variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT gonzaleznoeliagarcia variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain AT callemiguellaura variationinsarscov2seroprevalenceinchildrenintheregionofasturiasnorthernspain |